AbouEzzeddine, O. F., Kane, G. C., Rodeheffer, R. J., Chen, H. H., Saenger, A. K., Scott, C. G., … Redfield, M. M. (2012). Plasma Levels of ST2 in the Community: ST2 is Associated with Increased Risk of Incident Heart Failure and Mortality but not with Altered Ventricular Function. In CIRCULATION (Vol. 126).

AbouEzzeddine, Omar F., Garvan C. Kane, Richard J. Rodeheffer, Horng H. Chen, Amy K. Saenger, Christopher G. Scott, Michael Felker, Allan S. Jaffe, John C. Burnett, and Margaret M. Redfield. “Plasma Levels of ST2 in the Community: ST2 is Associated with Increased Risk of Incident Heart Failure and Mortality but not with Altered Ventricular Function.” In CIRCULATION, Vol. 126, 2012.

AbouEzzeddine OF, Kane GC, Rodeheffer RJ, Chen HH, Saenger AK, Scott CG, et al. Plasma Levels of ST2 in the Community: ST2 is Associated with Increased Risk of Incident Heart Failure and Mortality but not with Altered Ventricular Function. In: CIRCULATION. 2012.

AbouEzzeddine, Omar F., et al. “Plasma Levels of ST2 in the Community: ST2 is Associated with Increased Risk of Incident Heart Failure and Mortality but not with Altered Ventricular Function.” CIRCULATION, vol. 126, no. 21, 2012.

AbouEzzeddine OF, Kane GC, Rodeheffer RJ, Chen HH, Saenger AK, Scott CG, Felker M, Jaffe AS, Burnett JC, Redfield MM. Plasma Levels of ST2 in the Community: ST2 is Associated with Increased Risk of Incident Heart Failure and Mortality but not with Altered Ventricular Function. CIRCULATION. 2012.